Quantcast

Latest Systemic lupus erythematosus Stories

2014-04-10 12:27:11

America's largest lupus walk program takes place at South Street Seaport on Saturday, May 3 NEW YORK, April 10, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will host its 2014 annual Walk To End Lupus Now(TM)( )event in New York City on Saturday, May 3 at the South Street Seaport. The largest lupus walk program in the country, Walk to End Lupus Now events are held in more than 60 cities, bringing together community members--lupus patients, friends, families,...

2014-04-04 23:38:31

Lupus Bible And Norton Protocol is developed by Julia Liu, who claims to teach people how to treat their lupus quickly and naturally. An overview on the website Vinaf.com shows if the program is worth buying. New York, NY (PRWEB) April 03, 2014 Lupus Bible And Norton Protocol is the latest program that provides people natural remedies, techniques, tips, and detailed instructions on how treat their lupus. In the program, people will discover all important information about lupus such as...

2014-04-03 08:27:41

Lupus Science & Medicine is launched to provide the latest lupus research and stimulate collaborative efforts to improving the lives of all people affected by lupus WASHINGTON, April 3, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America and BMJ announced today the launch and publication of the first scientific research articles in Lupus Science & Medicine(TM). Lupus Science & Medicine is a peer reviewed, Open Access, online journal that provides a central point for...

2014-04-01 13:02:44

Antibiotics being explored for the treatment of cystic fibrosis and muscular dystrophy have the potential to trigger autoimmune disease The code for every gene includes a message at the end of it that signals the translation machinery to stop. Some diseases, such as cystic fibrosis and Duchenne muscular dystrophy, can result from mutations that insert this stop signal into the middle of an essential gene, causing the resulting protein to be truncated. Some antibiotics cause the cell's...

2014-04-01 08:28:06

- Agreement aims to identify biomarkers relevant to future therapies in the area of Systemic Lupus Erythematosus and Lupus Nephritis ROCKLAND, Mass., April 1, 2014 /PRNewswire/ -- EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced they have signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S. The collaboration is focused on the genomic profiling of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN)...

2014-03-27 12:27:48

New England Patriots defensive back Tavon Wilson serves as Walk Ambassador WASHINGTON, March 27, 2014 /PRNewswire-USNewswire/ -- Multi-talented entertainer and television personality Nick Cannon will serve as the Grand Marshal at the Walk to End Lupus Now(TM) event in Washington, D.C. on Saturday, April 19. Cannon will cut the opening ceremony ribbon and lead the more 4,000 walkers down Pennsylvania Avenue towards the Capitol, shedding light on the cruel mystery that is lupus....

2014-03-25 08:29:48

HERZLIYA, Israel, March 25, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, today announced the appointment of Daniel J. Wallace, MD and Murray Urowitz, MD, two experts in rheumatology, as consultants for the planned Phase II trial for the Company's hCDR1...

2014-03-20 12:32:58

LFA-REAL(TM) System is first of its kind tool to bring patients deeply into the development process WASHINGTON, March 20, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America announced today that it is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL((TM))(Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential...

2014-03-18 23:02:43

Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com. According to the report, new product launches are set to fuel SLE and LN treatment markets expansion through to 2022. London, UK (PRWEB) March 18, 2014 The systemic Lupus Erythematosus (SLE) treatment market in the 7 major nations (the US, Germany, France, the UK, Italy, Japan,...

2014-03-17 12:27:32

--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, March 17, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of clinical studies with its lead compound RSLV-132. Resolve administered the first doses to humans of RSLV-132 its first-in-class targeted nuclease therapy designed to decrease the burden of circulating RNA-containing immune complexes in SLE patients. Ongoing studies are designed to evaluate the safety, tolerability,...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related